# Study of Phenethyl Isothiocyanate in Lymphoproliferative Disorders

> **NCT00968461** · PHASE1 · WITHDRAWN · sponsor: **M.D. Anderson Cancer Center**

## Conditions studied

- Leukemia
- Lymphoproliferative Disorders

## Interventions

- **DRUG:** Phenethyl Isothiocyanate (PEITC)

## Key facts

- **NCT ID:** NCT00968461
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-05
- **Primary completion:** 2015-05
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00968461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00968461, "Study of Phenethyl Isothiocyanate in Lymphoproliferative Disorders". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00968461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*